The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
1 Report Overview 1.1 Study Scope and Definition 1.2 Research Methodology 1.2.1 Methodology/Research Approach 1.2.2 Data Source 1.3 Key Market Segments 1.4 Players Covered: Ranking by Opioid Induced Constipation (OIC) Drug Revenue 1.5 Market Analysis by Type 1.5.1 Global Opioid Induced Constipation (OIC) Drug Market Size Growth Rate by Type: 2020 VS 2026 1.5.2 Lubiprostone 1.5.3 Methyl Naltrexone Bromide 1.5.4 Naldemedine 1.5.5 Alvimopan 1.5.6 Other 1.6 Market by Application 1.6.1 Global Opioid Induced Constipation (OIC) Drug Market Share by Application: 2021-2026 1.6.2 Hospital Pharmacies 1.6.3 Retail Pharmacies 1.6.4 Online Pharmacies 1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth 1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections 1.7.2 Covid-19 Impact: Commodity Prices Indices 1.7.3 Covid-19 Impact: Global Major Government Policy 1.8 Study Objectives 1.9 Years Considered 2 Global Opioid Induced Constipation (OIC) Drug Market Trends and Growth Strategy 2.1 Market Top Trends 2.2 Market Drivers 2.3 Market Challenges 2.4 Porter's Five Forces Analysis 2.5 Market Growth Strategy 2.6 SWOT Analysis 3 Global Opioid Induced Constipation (OIC) Drug Market Players Profiles 3.1 Ironwood Pharmaceuticals 3.1.1 Ironwood Pharmaceuticals Company Profile 3.1.2 Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product Specification 3.1.3 Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.2 Purdue Pharma 3.2.1 Purdue Pharma Company Profile 3.2.2 Purdue Pharma Opioid Induced Constipation (OIC) Drug Product Specification 3.2.3 Purdue Pharma Opioid Induced Constipation (OIC) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.3 Progenics Pharmaceuticals 3.3.1 Progenics Pharmaceuticals Company Profile 3.3.2 Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product Specification 3.3.3 Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.4 Daiichi Sankyo Co 3.4.1 Daiichi Sankyo Co Company Profile 3.4.2 Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Product Specification 3.4.3 Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.5 Nektar Therapeutics 3.5.1 Nektar Therapeutics Company Profile 3.5.2 Nektar Therapeutics Opioid Induced Constipation (OIC) Drug Product Specification 3.5.3 Nektar Therapeutics Opioid Induced Constipation (OIC) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.6 Pfizer 3.6.1 Pfizer Company Profile 3.6.2 Pfizer Opioid Induced Constipation (OIC) Drug Product Specification 3.6.3 Pfizer Opioid Induced Constipation (OIC) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.7 Mundipharma International Limited 3.7.1 Mundipharma International Limited Company Profile 3.7.2 Mundipharma International Limited Opioid Induced Constipation (OIC) Drug Product Specification 3.7.3 Mundipharma International Limited Opioid Induced Constipation (OIC) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.8 Allergan 3.8.1 Allergan Company Profile 3.8.2 Allergan Opioid Induced Constipation (OIC) Drug Product Specification 3.8.3 Allergan Opioid Induced Constipation (OIC) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.9 Shionogi & 3.9.1 Shionogi & Company Profile 3.9.2 Shionogi & Opioid Induced Constipation (OIC) Drug Product Specification 3.9.3 Shionogi & Opioid Induced Constipation (OIC) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.10 S.L.A. Pharma 3.10.1 S.L.A. Pharma Company Profile 3.10.2 S.L.A. Pharma Opioid Induced Constipation (OIC) Drug Product Specification 3.10.3 S.L.A. Pharma Opioid Induced Constipation (OIC) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.11 Cosmo Pharmaceuticals SA 3.11.1 Cosmo Pharmaceuticals SA Company Profile 3.11.2 Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drug Product Specification 3.11.3 Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.12 Sucampo Pharmaceuticals 3.12.1 Sucampo Pharmaceuticals Company Profile 3.12.2 Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product Specification 3.12.3 Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.13 Ono Pharmaceutical 3.13.1 Ono Pharmaceutical Company Profile 3.13.2 Ono Pharmaceutical Opioid Induced Constipation (OIC) Drug Product Specification 3.13.3 Ono Pharmaceutical Opioid Induced Constipation (OIC) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.14 Daewoong Pharmaceutical 3.14.1 Daewoong Pharmaceutical Company Profile 3.14.2 Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drug Product Specification 3.14.3 Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.15 Bausch Health 3.15.1 Bausch Health Company Profile 3.15.2 Bausch Health Opioid Induced Constipation (OIC) Drug Product Specification 3.15.3 Bausch Health Opioid Induced Constipation (OIC) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.16 Takeda Pharmaceutical Company Limited 3.16.1 Takeda Pharmaceutical Company Limited Company Profile 3.16.2 Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drug Product Specification 3.16.3 Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.17 C.B. Fleet Company 3.17.1 C.B. Fleet Company Company Profile 3.17.2 C.B. Fleet Company Opioid Induced Constipation (OIC) Drug Product Specification 3.17.3 C.B. Fleet Company Opioid Induced Constipation (OIC) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.18 Theravance Biopharma 3.18.1 Theravance Biopharma Company Profile 3.18.2 Theravance Biopharma Opioid Induced Constipation (OIC) Drug Product Specification 3.18.3 Theravance Biopharma Opioid Induced Constipation (OIC) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020) 4 Global Opioid Induced Constipation (OIC) Drug Market Competition by Market Players 4.1 Global Opioid Induced Constipation (OIC) Drug Production Capacity Market Share by Market Players (2015-2020) 4.2 Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Market Players (2015-2020) 4.3 Global Opioid Induced Constipation (OIC) Drug Average Price by Market Players (2015-2020) 5 Global Opioid Induced Constipation (OIC) Drug Production by Regions (2015-2020) 5.1 North America 5.1.1 North America Opioid Induced Constipation (OIC) Drug Market Size (2015-2020) 5.1.2 Opioid Induced Constipation (OIC) Drug Key Players in North America (2015-2020) 5.1.3 North America Opioid Induced Constipation (OIC) Drug Market Size by Type (2015-2020) 5.1.4 North America Opioid Induced Constipation (OIC) Drug Market Size by Application (2015-2020) 5.2 East Asia 5.2.1 East Asia Opioid Induced Constipation (OIC) Drug Market Size (2015-2020) 5.2.2 Opioid Induced Constipation (OIC) Drug Key Players in East Asia (2015-2020) 5.2.3 East Asia Opioid Induced Constipation (OIC) Drug Market Size by Type (2015-2020) 5.2.4 East Asia Opioid Induced Constipation (OIC) Drug Market Size by Application (2015-2020) 5.3 Europe 5.3.1 Europe Opioid Induced Constipation (OIC) Drug Market Size (2015-2020) 5.3.2 Opioid Induced Constipation (OIC) Drug Key Players in Europe (2015-2020) 5.3.3 Europe Opioid Induced Constipation (OIC) Drug Market Size by Type (2015-2020) 5.3.4 Europe Opioid Induced Constipation (OIC) Drug Market Size by Application (2015-2020) 5.4 South Asia 5.4.1 South Asia Opioid Induced Constipation (OIC) Drug Market Size (2015-2020) 5.4.2 Opioid Induced Constipation (OIC) Drug Key Players in South Asia (2015-2020) 5.4.3 South Asia Opioid Induced Constipation (OIC) Drug Market Size by Type (2015-2020) 5.4.4 South Asia Opioid Induced Constipation (OIC) Drug Market Size by Application (2015-2020) 5.5 Southeast Asia 5.5.1 Southeast Asia Opioid Induced Constipation (OIC) Drug Market Size (2015-2020) 5.5.2 Opioid Induced Constipation (OIC) Drug Key Players in Southeast Asia (2015-2020) 5.5.3 Southeast Asia Opioid Induced Constipation (OIC) Drug Market Size by Type (2015-2020) 5.5.4 Southeast Asia Opioid Induced Constipation (OIC) Drug Market Size by Application (2015-2020) 5.6 Middle East 5.6.1 Middle East Opioid Induced Constipation (OIC) Drug Market Size (2015-2020) 5.6.2 Opioid Induced Constipation (OIC) Drug Key Players in Middle East (2015-2020) 5.6.3 Middle East Opioid Induced Constipation (OIC) Drug Market Size by Type (2015-2020) 5.6.4 Middle East Opioid Induced Constipation (OIC) Drug Market Size by Application (2015-2020) 5.7 Africa 5.7.1 Africa Opioid Induced Constipation (OIC) Drug Market Size (2015-2020) 5.7.2 Opioid Induced Constipation (OIC) Drug Key Players in Africa (2015-2020) 5.7.3 Africa Opioid Induced Constipation (OIC) Drug Market Size by Type (2015-2020) 5.7.4 Africa Opioid Induced Constipation (OIC) Drug Market Size by Application (2015-2020) 5.8 Oceania 5.8.1 Oceania Opioid Induced Constipation (OIC) Drug Market Size (2015-2020) 5.8.2 Opioid Induced Constipation (OIC) Drug Key Players in Oceania (2015-2020) 5.8.3 Oceania Opioid Induced Constipation (OIC) Drug Market Size by Type (2015-2020) 5.8.4 Oceania Opioid Induced Constipation (OIC) Drug Market Size by Application (2015-2020) 5.9 South America 5.9.1 South America Opioid Induced Constipation (OIC) Drug Market Size (2015-2020) 5.9.2 Opioid Induced Constipation (OIC) Drug Key Players in South America (2015-2020) 5.9.3 South America Opioid Induced Constipation (OIC) Drug Market Size by Type (2015-2020) 5.9.4 South America Opioid Induced Constipation (OIC) Drug Market Size by Application (2015-2020) 5.10 Rest of the World 5.10.1 Rest of the World Opioid Induced Constipation (OIC) Drug Market Size (2015-2020) 5.10.2 Opioid Induced Constipation (OIC) Drug Key Players in Rest of the World (2015-2020) 5.10.3 Rest of the World Opioid Induced Constipation (OIC) Drug Market Size by Type (2015-2020) 5.10.4 Rest of the World Opioid Induced Constipation (OIC) Drug Market Size by Application (2015-2020) 6 Global Opioid Induced Constipation (OIC) Drug Consumption by Region (2015-2020) 6.1 North America 6.1.1 North America Opioid Induced Constipation (OIC) Drug Consumption by Countries 6.1.2 United States 6.1.3 Canada 6.1.4 Mexico 6.2 East Asia 6.2.1 East Asia Opioid Induced Constipation (OIC) Drug Consumption by Countries 6.2.2 China 6.2.3 Japan 6.2.4 South Korea 6.3 Europe 6.3.1 Europe Opioid Induced Constipation (OIC) Drug Consumption by Countries 6.3.2 Germany 6.3.3 United Kingdom 6.3.4 France 6.3.5 Italy 6.3.6 Russia 6.3.7 Spain 6.3.8 Netherlands 6.3.9 Switzerland 6.3.10 Poland 6.4 South Asia 6.4.1 South Asia Opioid Induced Constipation (OIC) Drug Consumption by Countries 6.4.2 India 6.5 Southeast Asia 6.5.1 Southeast Asia Opioid Induced Constipation (OIC) Drug Consumption by Countries 6.5.2 Indonesia 6.5.3 Thailand 6.5.4 Singapore 6.5.5 Malaysia 6.5.6 Philippines 6.6 Middle East 6.6.1 Middle East Opioid Induced Constipation (OIC) Drug Consumption by Countries 6.6.2 Turkey 6.6.3 Saudi Arabia 6.6.4 Iran 6.6.5 United Arab Emirates 6.7 Africa 6.7.1 Africa Opioid Induced Constipation (OIC) Drug Consumption by Countries 6.7.2 Nigeria 6.7.3 South Africa 6.8 Oceania 6.8.1 Oceania Opioid Induced Constipation (OIC) Drug Consumption by Countries 6.8.2 Australia 6.9 South America 6.9.1 South America Opioid Induced Constipation (OIC) Drug Consumption by Countries 6.9.2 Brazil 6.9.3 Argentina 6.10 Rest of the World 6.10.1 Rest of the World Opioid Induced Constipation (OIC) Drug Consumption by Countries 7 Global Opioid Induced Constipation (OIC) Drug Production Forecast by Regions (2021-2026) 7.1 Global Forecasted Production of Opioid Induced Constipation (OIC) Drug (2021-2026) 7.2 Global Forecasted Revenue of Opioid Induced Constipation (OIC) Drug (2021-2026) 7.3 Global Forecasted Price of Opioid Induced Constipation (OIC) Drug (2021-2026) 7.4 Global Forecasted Production of Opioid Induced Constipation (OIC) Drug by Region (2021-2026) 7.4.1 North America Opioid Induced Constipation (OIC) Drug Production, Revenue Forecast (2021-2026) 7.4.2 East Asia Opioid Induced Constipation (OIC) Drug Production, Revenue Forecast (2021-2026) 7.4.3 Europe Opioid Induced Constipation (OIC) Drug Production, Revenue Forecast (2021-2026) 7.4.4 South Asia Opioid Induced Constipation (OIC) Drug Production, Revenue Forecast (2021-2026) 7.4.5 Southeast Asia Opioid Induced Constipation (OIC) Drug Production, Revenue Forecast (2021-2026) 7.4.6 Middle East Opioid Induced Constipation (OIC) Drug Production, Revenue Forecast (2021-2026) 7.4.7 Africa Opioid Induced Constipation (OIC) Drug Production, Revenue Forecast (2021-2026) 7.4.8 Oceania Opioid Induced Constipation (OIC) Drug Production, Revenue Forecast (2021-2026) 7.4.9 South America Opioid Induced Constipation (OIC) Drug Production, Revenue Forecast (2021-2026) 7.4.10 Rest of the World Opioid Induced Constipation (OIC) Drug Production, Revenue Forecast (2021-2026) 7.5 Forecast by Type and by Application (2021-2026) 7.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026) 7.5.2 Global Forecasted Consumption of Opioid Induced Constipation (OIC) Drug by Application (2021-2026) 8 Global Opioid Induced Constipation (OIC) Drug Consumption Forecast by Regions (2021-2026) 8.1 North America Forecasted Consumption of Opioid Induced Constipation (OIC) Drug by Country 8.2 East Asia Market Forecasted Consumption of Opioid Induced Constipation (OIC) Drug by Country 8.3 Europe Market Forecasted Consumption of Opioid Induced Constipation (OIC) Drug by Countriy 8.4 South Asia Forecasted Consumption of Opioid Induced Constipation (OIC) Drug by Country 8.5 Southeast Asia Forecasted Consumption of Opioid Induced Constipation (OIC) Drug by Country 8.6 Middle East Forecasted Consumption of Opioid Induced Constipation (OIC) Drug by Country 8.7 Africa Forecasted Consumption of Opioid Induced Constipation (OIC) Drug by Country 8.8 Oceania Forecasted Consumption of Opioid Induced Constipation (OIC) Drug by Country 8.9 South America Forecasted Consumption of Opioid Induced Constipation (OIC) Drug by Country 8.10 Rest of the world Forecasted Consumption of Opioid Induced Constipation (OIC) Drug by Country 9 Global Opioid Induced Constipation (OIC) Drug Sales by Type (2015-2026) 9.1 Global Opioid Induced Constipation (OIC) Drug Historic Market Size by Type (2015-2020) 9.2 Global Opioid Induced Constipation (OIC) Drug Forecasted Market Size by Type (2021-2026) 10 Global Opioid Induced Constipation (OIC) Drug Consumption by Application (2015-2026) 10.1 Global Opioid Induced Constipation (OIC) Drug Historic Market Size by Application (2015-2020) 10.2 Global Opioid Induced Constipation (OIC) Drug Forecasted Market Size by Application (2021-2026) 11 Global Opioid Induced Constipation (OIC) Drug Manufacturing Cost Analysis 11.1 Opioid Induced Constipation (OIC) Drug Key Raw Materials Analysis 11.1.1 Key Raw Materials 11.2 Proportion of Manufacturing Cost Structure 11.3 Manufacturing Process Analysis of Opioid Induced Constipation (OIC) Drug 12 Global Opioid Induced Constipation (OIC) Drug Marketing Channel, Distributors, Customers and Supply Chain 12.1 Marketing Channel 12.2 Opioid Induced Constipation (OIC) Drug Distributors List 12.3 Opioid Induced Constipation (OIC) Drug Customers 12.4 Opioid Induced Constipation (OIC) Drug Supply Chain Analysis 13 Analyst's Viewpoints/Conclusions 14 Disclaimer
Price : US$ 3,500 | Date : Mar 2024 |
Category : Healthcare and Pharmaceuticals | Pages : 139 |
Price : US$ 3,500 | Date : Mar 2024 |
Category : Healthcare and Pharmaceuticals | Pages : 200 |
Price : US$ 2,450 | Date : Feb 2024 |
Category : Healthcare and Pharmaceuticals | Pages : 254 |
Price : US$ 2,450 | Date : Feb 2024 |
Category : Healthcare and Pharmaceuticals | Pages : 250 |
Price : US$ 3,500 | Date : Mar 2024 |
Category : Healthcare and Pharmaceuticals | Pages : 143 |
We will be happy to help you find what you need. Please call us or write to us: